Skip to main content
. 2015 Feb 20;79(3):477–491. doi: 10.1111/bcp.12513

Figure 2.

Figure 2

(A) Mean (± SD) selisistat AUC0–24m h) following single doses between 5 and 600 mg in males (•) and females (Inline graphic). The dashed line represents the NOAEL exposure. (B) Mean (± SD) selisistat AUC(0,24 h) (μm h) following repeated doses between 100 and 300 mg once daily in males (•) and females (Inline graphic). The dashed line represents the NOAEL exposure